Examples of inhibitors
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Examples of Enzyme Inhibitors
Enzyme inhibitors are molecules that bind to enzymes and decrease their activity. They play a crucial role in various biochemical processes and therapeutic applications. This article explores different types of enzyme inhibitors, their mechanisms, and examples from recent research.
Covalent Enzyme Inhibitors
Reversible and Irreversible Covalent Inhibitors
Covalent enzyme inhibitors form a covalent bond with their target enzyme, leading to either reversible or irreversible inhibition. Reversible covalent inhibitors form a temporary bond that can be broken, while irreversible inhibitors form a permanent bond, leading to long-lasting inhibition. Examples include covalent reversible inhibitors, slow substrates, residue-specific reagents, affinity labels, and mechanism-based inactivators.
Selectivity and Safety Concerns
Covalent inhibitors are known for their high biochemical efficiency and prolonged duration of action. However, they must be designed carefully to avoid off-target effects and potential immunogenicity. Recent technologies, such as activity-based protein profiling, help in assessing the selectivity of covalent inhibitors, ensuring they target only the intended proteins.
Examples of Covalent Inhibitors
Successful drugs that act as covalent inhibitors include those targeting fatty acid amide hydrolase and other emerging therapeutic targets. These inhibitors are modified with 'clickable' tags to generate activity probes, allowing comprehensive profiling of their on- and off-target effects in living systems.
Enzyme Inhibitors in Drug Development
Monoamine Oxidase and Cholinesterase Inhibitors
Inhibitors of monoamine oxidases (MAO) and cholinesterases (ChE) are widely used in pharmacology. These inhibitors are assessed based on their IC50 values, which indicate the concentration needed to inhibit 50% of enzyme activity. Multi-target-directed ligands (MTDLs) that combine MAO and ChE inhibitory functions are also being developed, requiring careful assessment to ensure their efficacy and specificity.
Protein-Protein Interaction Inhibitors
Small-molecule inhibitors of protein-protein interactions mimic natural protein partners to disrupt these interactions. These inhibitors employ various binding strategies and chemotypes, making them promising candidates for drug discovery. The flexibility in binding strategies suggests a favorable outlook for finding effective small-molecule inhibitors for protein-protein interactions.
Plant-Derived Proteinase Inhibitors
Bowman-Birk Inhibitors
Wheat germ trypsin inhibitors, classified into single-headed and double-headed types, are examples of plant-derived proteinase inhibitors. These inhibitors show high homology to Bowman-Birk inhibitors found in Leguminosae plants. Single-headed inhibitors are considered relics of ancestral forms before gene duplication led to the current double-headed inhibitors.
Structural and Mechanistic Insights
Plant proteinase inhibitors target serine proteinases, carboxypeptidases, and cysteine proteinases. They maintain compact and stable inhibitory domains that bind to the active site of target proteinases, preventing substrate access. The knottin group is a notable example, with different families utilizing the knottin fold to inhibit various proteinases.
Cross-Class Inhibition
CrmA Serpin and Interleukin-1 Beta Converting Enzyme
The cowpox virus serpin CrmA inhibits the human interleukin-1 beta converting enzyme (ICE), a cysteine proteinase, despite serpins typically inhibiting serine proteinases. This cross-class inhibition is due to the substrate binding geometry of ICE, which resembles that of serine proteinases, allowing CrmA to form a tight inhibitory complex with ICE.
Conclusion
Enzyme inhibitors are diverse in their mechanisms and applications, ranging from covalent inhibitors with high selectivity to plant-derived proteinase inhibitors with unique structural features. Understanding these inhibitors' mechanisms and examples can aid in developing more effective therapeutic agents and biochemical tools.
Sources and full results
Most relevant research papers on this topic